MALAT1 and nasopharyngeal carcinoma: In the serum circulation of NPC patients, lncRNA MALAT1, APAF1-AS1 and AL359062 are markedly up-regulated and correlated with poor prognosis, indicating that they can be used as biomarkers for predicting poor outcome of NPC141.